ICD-10-CM · Billable Code
R97.21 — Rising PSA fol treatment for malignant neoplasm of prostate
Rising PSA following treatment for malignant neoplasm of prostate
Chapter R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Need plain-language info on this diagnosis?
Ask GoDavaii AI about Rising PSA fol treatment for malignant neoplasm of prostateRelated diagnoses
Common questions about R97.21 (Rising PSA fol treatment for malignant neoplasm of prostate)
What does ICD-10 code R97.21 mean?
R97.21 is the ICD-10-CM 2025 code for Rising PSA fol treatment for malignant neoplasm of prostate. Rising PSA following treatment for malignant neoplasm of prostate. ICD-10-CM is the medical coding system used by clinicians, hospitals and insurers worldwide to classify diseases and conditions in a standard way.
Is R97.21 a billable diagnosis code?
Yes, R97.21 is a billable / specific ICD-10-CM code, meaning it can be used by clinicians and hospitals as a primary or secondary diagnosis on claims and electronic health records.
Which ICD-10 chapter does R97.21 belong to?
R97.21 belongs to the chapter "Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified" (codes R00-R99). ICD-10-CM organises codes into 22 chapters by body system or condition type, which helps clinicians navigate related diagnoses.
Where can I get plain-language information about Rising PSA fol treatment for malignant neoplasm of prostate?
For a plain-language explanation of Rising PSA fol treatment for malignant neoplasm of prostate, ask GoDavaii's Health AI - it explains medical conditions in 22+ Indian languages, free, with no signup. Tap "Ask GoDavaii AI about Rising PSA fol treatment for malignant neoplasm of prostate" above to get a personalised answer.
Source: ICD-10-CM 2025 (Centers for Medicare & Medicaid Services, public domain). Codes valid from October 1, 2024. CMS source ↗